Yıl: 2022 Cilt: 23 Sayı: 2 Sayfa Aralığı: 90 - 95 Metin Dili: İngilizce DOI: 10.4274/imj.galenos.2022.28445 İndeks Tarihi: 17-06-2022

Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome

Öz:
Introduction: Polycystic ovary syndrome (PCOS) is one of the most common endocrine abnormalities of reproductive age and has a highly heterogeneous nature regarding its multisystemic symptoms. To elicit pathophysiological roots, metabolic mapping and between-correlations among key parameters are of vital importance. We generated a platform including cardinal hormones, lipids, homeostasis model assessment of insulin resistance (HOMA-IR) and oxidative markers [total-oxidant status (TOS), total antioxidant status (TAS), oxidative stress index (OSI), copper (Cu)] related to pathophysiology. Methods: This prospective case-control study included 46 patients with PCOS and 44 non-PCOS healthy women. Samples were obtained from the Obstetrics and Gynecology Clinic of University of Health Sciences Turkey, İstanbul Training and Research Hospital. TAS, TOS, and Cu levels were measured by automated methods. Results: Anti-Mullerian hormone, total testosterone (TT), dehydroepiandrosterone sulfate, low-density lipoprotein, high-density lipoprotein (HDL), total cholesterol, TOS, OSI were increased in patients with PCOS with no significant differences in the mean values of other parameters. ROC analysis revealed that TOS and OSI had an acceptable predictive value for PCOS diagnosis. Plasma HOMA-IR, triglyceride, HDL, TT, and sex-hormone-binding globulin levels were correlated with OS markers. Conclusion: Redox status was found to be sensitive to hormonal alterations. Metabolites were then were compared with the oxidative markers to reveal any relationship that may explain the causal link between metabolic and redox changes Ultimately, evaluating broad-based metabolic profiling of patients, the current study contributes to the literature, which has controversial data and correlation findings poses new questions requiring further research to elicit underlying mechanisms and so to set new targets for both prevention and treatment.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
0
0
0
  • 1. Murri M, Luque-Ramírez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 2013; 19: 268-88.
  • 2. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem 2005; 2: 1161-208.
  • 3. Kanafchian M, Esmaeilzadeh S, Mahjoub S, Rahsepar M, Ghasemi M. Status of Serum Copper, Magnesium, and Total Antioxidant Capacity in Patients with Polycystic Ovary Syndrome. Biol Trace Elem Res 2020; 193: 111-7.
  • 4. Celik C, Bastu E, Abali R, Alpsoy S, Guzel EC, Aydemir B, et al. The relationship between copper, homocysteine and early vascular disease in lean women with polycystic ovary syndrome. Gynecol Endocrinol 2013; 29: 488-91.
  • 5. Zheng G, Wang L, Guo Z, Sun L, Wang L, Wang C, et al. Association of Serum Heavy Metals and Trace Element Concentrations with Reproductive Hormone Levels and Polycystic Ovary Syndrome in a Chinese Population. Biol Trace Elem Res 2015; 167: 1-10.
  • 6. Bizoń A, Słowiak A, Franik G, Biernacka-Bartnik A, Madej P. Zinc, copper, sirtuin 1 concentration, and glucose metabolism parameters in the blood of women with polycystic ovary syndrome. Gynecol Endocrinol 2020; 36: 951-4.
  • 7. Revathi R, Julius A, Singaravelu S. Correlation of serum copper, zinc, magnesium with insulin resistance in PCOS female of reproductive age group. Int J Pharm Res 2018; 10: 789-92.
  • 8. Yin J, Hong X, Ma J, Bu Y, Liu R. Serum Trace Elements in Patients With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2020; 11: 572384.
  • 9. Hilali N, Vural M, Camuzcuoglu H, Camuzcuoglu A. Increased prolidase activity and oxidative stress in PCOS. Clin Endocrinol 2013; 79: 105-10.
  • 10. Beyazit F, Yilmaz N, Balci O, Adam M, Yaman ST. Evaluation of Oxidative Stress in Women with Polycystic Ovarian Syndrome as Represented by Serum Ischemia Modified Albumin and Its Correlation with Testosterone and Insulin Resistance. Intern Med 2016; 55: 2359-64.
  • 11. Zhang R, Liu H, Bai H Liu Q, Guan L, Fan P. Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2017; 86: 88-96.
  • 12. Lizneva D, Suturina L, Walker W, Brakta S, Brakta S, Gavrilova-Jordan L, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 2016; 106: 6-15.
  • 13. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277-85.
  • 14. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103-11.
  • 15. Malini NA, Roy George K. Evaluation of different ranges of LH:FSH ratios in polycystic ovarian syndrome (PCOS) - Clinical based case control study. Gen Comp Endocrinol 2018; 260: 51-7.
  • 16. Arshad FA, Mehmood R, Kausar N, Bibi A, Khan MA, Hussain S, et al. Assessment and association between lipid and hormonal profile in nonpregnant females having polycystic ovarian syndrome. Endocrinol Metab Syndr 2019; 8: 1-5.
  • 17. Macut D, Bjekić-Macut J, Savić-Radojević A. Dyslipidemia and oxidative stress in PCOS. Front Horm Res 2013; 40: 51-63.
  • 18. Paschou SA, Palioura E, Ioannidis D, Anagnostis P, Panagiotakou A, Loi V, et al. Adrenal hyperandrogenism does not deteriorate insulin resistance and lipid profile in women with PCOS. Endocr Connect 2017 ;6: 601-6.
  • 19. Verit FF, Erel O. Oxidative stress in nonobese women with polycystic ovary syndrome: correlations with endocrine and screening parameters. Gynecol Obstet Invest 2008; 65: 233-9.
  • 20. Lazúrová I, Lazúrová Z, Figurová J, Ujházi S, Dravecká I, Mašlanková J, et al. Relationship between steroid hormones and metabolic profile in women with polycystic ovary syndrome. Physiol Res 2019; 68: 457-65.
  • 21. Spałkowska M, Mrozińska S, Gałuszka-Bednarczyk A, Gosztyła K, Przywara A, Guzik J, et al. The PCOS Patients differ in Lipid Profile According to their Phenotypes. Exp Clin Endocrin Diabetes 2018; 126: 437-44.
  • 22. Li R, Yu G, Yang D, Li S, Lu S, Wu X, et al. Prevalence and predictors of metabolic abnormalities in Chinese women with PCOS: a cross- sectional study. BMC Endocr Disord 2014; 14: 76.
  • 23. Torun AN, Vural M, Cece H, Camuzcuoglu H, Toy H, Aksoy N. Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered. Gynecol Endocrinol 2011; 27: 988-92.
  • 24. Cakir E, Ozbek M, Ozkaya E, Colak N, Cakal E, Sayki M, et al. Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients. J Endocrinol Invest 2011; 34: e178-e82.
  • 25. Kiranmayee D, Kavya K, Himabindu Y, Sriharibabu M, Madhuri GLJ, Venu S. Correlations between anthropometry and lipid profile in women with PCOS. J Hum Reprod Sci 2017; 10: 167-72.
  • 26. Roe A, Hillman J, Butts S, Smith M, Rader D, Playford M, et al. Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS. J Clin Endocrinol Metab 2014; 99: E841-E7.
  • 27. Kirmizi DA, Baser E, Turksoy VA, Kara M, Yalvac ES, Gocmen AY. Are Heavy Metal Exposure and Trace Element Levels Related to Metabolic and Endocrine Problems in Polycystic Ovary Syndrome?. Biol Trace Elem Res 2020; 198: 77-86.
  • 28. Sak S, Uyanikoglu H, Incebiyik A, Incebiyik H, Hilali NG, Sabuncu T, et al. Associations of serum fetuin-A and oxidative stress parameters with polycystic ovary syndrome. Clin Exp Reprod Med 2018; 45: 116-21.
  • 29. Uyanikoglu H, Sabuncu T, Dursun H, Sezen H, Aksoy N. Circulating levels of apoptotic markers and oxidative stress parameters in women with polycystic ovary syndrome: a case-controlled descriptive study. Biomarkers 2017; 22: 643-7
APA Atakul N, SELEK Ş, KÖKTAŞOĞLU F, kılıç b, GÜL A, ATAMER Y (2022). Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome. , 90 - 95. 10.4274/imj.galenos.2022.28445
Chicago Atakul Nil,SELEK Şahabettin,KÖKTAŞOĞLU Fatmanur,kılıç berna şermin,GÜL AYŞE ZEHRA,ATAMER Yıldız Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome. (2022): 90 - 95. 10.4274/imj.galenos.2022.28445
MLA Atakul Nil,SELEK Şahabettin,KÖKTAŞOĞLU Fatmanur,kılıç berna şermin,GÜL AYŞE ZEHRA,ATAMER Yıldız Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome. , 2022, ss.90 - 95. 10.4274/imj.galenos.2022.28445
AMA Atakul N,SELEK Ş,KÖKTAŞOĞLU F,kılıç b,GÜL A,ATAMER Y Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome. . 2022; 90 - 95. 10.4274/imj.galenos.2022.28445
Vancouver Atakul N,SELEK Ş,KÖKTAŞOĞLU F,kılıç b,GÜL A,ATAMER Y Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome. . 2022; 90 - 95. 10.4274/imj.galenos.2022.28445
IEEE Atakul N,SELEK Ş,KÖKTAŞOĞLU F,kılıç b,GÜL A,ATAMER Y "Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome." , ss.90 - 95, 2022. 10.4274/imj.galenos.2022.28445
ISNAD Atakul, Nil vd. "Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome". (2022), 90-95. https://doi.org/10.4274/imj.galenos.2022.28445
APA Atakul N, SELEK Ş, KÖKTAŞOĞLU F, kılıç b, GÜL A, ATAMER Y (2022). Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome. İstanbul Medical Journal, 23(2), 90 - 95. 10.4274/imj.galenos.2022.28445
Chicago Atakul Nil,SELEK Şahabettin,KÖKTAŞOĞLU Fatmanur,kılıç berna şermin,GÜL AYŞE ZEHRA,ATAMER Yıldız Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome. İstanbul Medical Journal 23, no.2 (2022): 90 - 95. 10.4274/imj.galenos.2022.28445
MLA Atakul Nil,SELEK Şahabettin,KÖKTAŞOĞLU Fatmanur,kılıç berna şermin,GÜL AYŞE ZEHRA,ATAMER Yıldız Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome. İstanbul Medical Journal, vol.23, no.2, 2022, ss.90 - 95. 10.4274/imj.galenos.2022.28445
AMA Atakul N,SELEK Ş,KÖKTAŞOĞLU F,kılıç b,GÜL A,ATAMER Y Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome. İstanbul Medical Journal. 2022; 23(2): 90 - 95. 10.4274/imj.galenos.2022.28445
Vancouver Atakul N,SELEK Ş,KÖKTAŞOĞLU F,kılıç b,GÜL A,ATAMER Y Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome. İstanbul Medical Journal. 2022; 23(2): 90 - 95. 10.4274/imj.galenos.2022.28445
IEEE Atakul N,SELEK Ş,KÖKTAŞOĞLU F,kılıç b,GÜL A,ATAMER Y "Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome." İstanbul Medical Journal, 23, ss.90 - 95, 2022. 10.4274/imj.galenos.2022.28445
ISNAD Atakul, Nil vd. "Impact of Copper and Oxidative Stress Index Levels on Insulin Resistance, Lipid Profile and Hormonal Status of Patients with Polycystic Ovary Syndrome". İstanbul Medical Journal 23/2 (2022), 90-95. https://doi.org/10.4274/imj.galenos.2022.28445